Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive tags : Preclinical save search
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Published: 2024-04-09 (Crawled : 12:30) - prnewswire.com
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: 2.36%
H: 6.6%
C: 1.32%
reqorsa lung report positive treatment system preclinical for meeting therapy
Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
Published: 2024-04-02 (Crawled : 12:30) - prnewswire.com
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: -5.72%
H: 7.14%
C: 1.43%
oncoprex positive system preclinical therapy
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Published: 2024-03-19 (Crawled : 15:30) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 21.74%
H: 19.29%
C: -3.57%
disease pre-clinical positive treatment alzheimer's therapeutics ht-alz study
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® and on NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex® Delivery System for the Treatment of Lung Cancers at the 2024 AACR Annual Meeting
Published: 2024-03-06 (Crawled : 13:30) - prnewswire.com
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: 24.27%
H: 5.66%
C: -14.45%
reqorsa lung positive treatment system preclinical meeting therapy
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
Published: 2024-03-05 (Crawled : 12:00) - globenewswire.com
MNPR | $0.636 -6.19% -6.6% 33K
|
Health Technology
|
| O: 5.04%
H: 15.38%
C: 1.92%
mnpr-101 positive preclinical program
Satellos Presents Positive Preclinical Efficacy Data for SAT-3247 at the 2024 MDA Clinical & Scientific Conference
Published: 2024-03-04 (Crawled : 22:00) - biospace.com/
MSCLF | $0.3901 18.14% 1K
|
n/a
|
| O: 2.24%
H: 0.0%
C: 0.0%
sat-3247 conference positive preclinical
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
Published: 2024-02-28 (Crawled : 19:00) - biospace.com/
VANI | $1.7 -5.82% -6.18% 190K
|
Manufacturing
|
| O: 499.01%
H: 28.93%
C: -38.18%
npm-115 ozempic obesity positive preclinical medical
MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer
Published: 2024-02-07 (Crawled : 00:00) - biospace.com/
MAIA | $2.15 9.69% 0.0% 100K
|
|
| O: 0.0%
H: 0.0%
C: -3.4%
lung positive cancer publication cell treatment communications potential
Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn’s & Colitis Congress
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
PALI | $4.735 -6.61% -7.07% 140K
|
Manufacturing
|
| O: 125.0%
H: 27.35%
C: -17.95%
pali-2108 congress positive preclinical program
Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: -7.38%
H: 7.89%
C: 6.31%
ata3431 positive preclinical meeting
Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models
Published: 2023-12-11 (Crawled : 13:00) - globenewswire.com
KTTA | $7.15 -1.19% 540
|
|
| O: 176.71%
H: 4.77%
C: -46.72%
pas-004 positive cancer preclinical therapeutics
Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics
Published: 2023-11-14 (Crawled : 13:30) - globenewswire.com
OCEA | $1.76 -6.13% -6.53% 200K
|
|
| O: -2.39%
H: 0.7%
C: -13.29%
vron-0300 positive preclinical therapeutics
GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
Published: 2023-11-06 (Crawled : 14:30) - globenewswire.com
GTBP | $3.8001 1.3% 5.9K
|
Manufacturing
|
| O: -3.42%
H: 21.59%
C: 3.54%
gtb-5550 trike positive cancer treatment biopharma preclinical immunotherapy meeting
Citius Pharmaceuticals Announces Publication in Frontiers of Immunology of Positive Results from Solid Tumor Study of LYMPHIR™ in Combination with Checkpoint Inhibitor
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: -1.33%
H: 4.64%
C: 1.7%
positive publication pharmaceuticals tumor immunology results study
VYNE Therapeutics Reports Positive Results from Preclinical Models for Oral BD2-Selective BET Inhibitor VYN202
Published: 2023-10-30 (Crawled : 11:00) - globenewswire.com
VYNE | $2.285 -0.65% -0.66% 19K
|
Health Technology
|
| O: 40.31%
H: 9.52%
C: -12.06%
vyn202 positive preclinical therapeutics results
Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss; Initiating Clinical Study of Melanocortin 4 Receptor Agonist + GLP-1 in Obese Patients
Published: 2023-10-18 (Crawled : 20:00) - biospace.com/
PTN | $1.84 -2.65% 0.05% 150K
|
Health Technology
|
| O: -3.41%
H: 5.79%
C: 1.76%
agonist positive preclinical study
Prime Medicine to Highlight Positive Preclinical Developments Across Prime Editing Pipeline and Platform at Upcoming Industry Conferences
Published: 2023-10-17 (Crawled : 12:00) - globenewswire.com
PRME | $4.52 -1.53% -1.55% 930K
|
|
| O: -2.71%
H: 14.24%
C: 13.07%
positive pipeline preclinical prime platform
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
XAIR | $1.22 2.52% 2.46% 280K
|
Technology Services
|
| O: 2.68%
H: 0.43%
C: -2.61%
conference beyond positive cancer international preclinical therapeutics therapy molecular
BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
BFRG | $2.71 -10.27% -11.44% 130K
|
n/a
|
| O: 8.71%
H: 37.18%
C: 13.78%
positive treatment preclinical glioblastoma study
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138Further Supports TTX-MC138 Application in Brain Cancer
Published: 2023-09-25 (Crawled : 17:00) - biospace.com/
RNAZ | $0.49 -2.39% -2.45% 110K
|
Professional, Scientific, and T...
|
| O: 97.29%
H: 144.27%
C: 94.66%
mc138 ttx-mc138 pre-clinical positive cancer application therapeutics results glioblastoma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.